AspenBio Pharma, Inc. (NASDAQ: APPY), an bio-science company focused on the development of novel diagnostics and drugs for humans and animals, has been invited to present at the Lazard Capital Market 6th Annual Healthcare Conference to be held November 17-18, 2009 at The St. Regis Hotel New York, NY.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
Management of the Company will be presenting on Tuesday, November 17, 2009 at 9:25 a.m. Eastern time, with one-on-one meetings held during the day.
The Company Representatives will discuss the company's progress, including its recently filed Premarket Notification 510(k) with the U.S. Food and Drug Administration for AppyScore™, the first blood-based test designed to aid in the diagnosing or ruling out human appendicitis. AspenBio will be advancing a new class of drugs that replace natural reproductive hormones for animals of economic importance. The company has a development and marketing agreement with Novartis Animal Health (NYSE: NVS) for the bovine species. Leading the presentation will be the company's executive chairman and CEO, Daryl Faulkner, who was previously president, CEO and board member of Digene Corp., a Nasdaq-traded company prior to its acquisition by Qiagen.
AspenBio Pharma's mission is to be a leader in the development and commercialization of innovative products that address unmet diagnostic and therapeutic needs in both Human and Animal Health. Our Human Health Division is addressing the difficult challenge of diagnosing appendicitis in the hospital emergency department setting. Our Animal Health Division is focused on therapeutic proteins that support reproductive efficiency in animals of economic importance.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
